Catalyst Wire Dossier Catalyst Wire Dossier

CTLA-4-Fc fusion protein

CTLA-4-Fc fusion protein · Beijing VDJBio Co., LTD.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CTLA-4-Fc fusion protein, covering 2024-05-07 to 2024-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Recombinant Humanized CTLA-4-FC Fusion Protein Injection in Healthy Subjects [Phase 1]

See pricing